Effects of Sibutramine Plus Orlistat in Obese Women Following 1 Year of Treatment by Sibutramine Alone: A Placebo‐Controlled Trial
Obesity Research2000Vol. 8(6), pp. 431–437
Citations Over TimeTop 10% of 2000 papers
Thomas A. Wadden, Robert I. Berkowitz, Leslie G. Womble, David B. Sarwer, Marjorie E. Arnold, C Steinberg
Abstract
These results must be interpreted with caution because of the study's small sample size. The findings, however, suggest that the combination of sibutramine and orlistat is unlikely to have additive effects that will yield mean losses > or =15% of initial weight, as desired by many obese individuals.
Related Papers
- → Currently Available Drugs for the Treatment of Obesity: Sibutramine and Orlistat(2006)91 cited
- [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].(1999)
- → Pharmacological Treatment of Obesity: Current Standards and Future Perspectives(2006)
- Sibutramine versus orlistat for obesity:A Meta-analysis of randomized controlled trials(2010)
- Obesity drugs: sibutramine and orlistat: sibutramine and orlistat(2002)